Portfolio (Quarterly)
Guide ↗
Opaleye Management Inc.
· CIK 0001595855| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ANNX | ANNEXON INC | Healthcare | 2,600,000.0 | $7.9M | 1.12% | NEW | — | $3.05 | +61.0% |
| 22 | GOSS | GOSSAMER BIO INC | Healthcare | 2,725,000.0 | $7.2M | 1.01% | NEW | — | $2.63 | -92.4% |
| 23 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 105,000.0 | $7.0M | 0.99% | NEW | — | $66.43 | +51.6% |
| 24 | DERM | JOURNEY MEDICAL CORP | Healthcare | 971,064.0 | $6.9M | 0.98% | NEW | — | $7.12 | -13.6% |
| 25 | SLGL | SOL GEL TECHNOLOGIES | Healthcare | 204,835.0 | $6.0M | 0.84% | NEW | — | $29.15 | +117.2% |
| 26 | PLX | PROTALIX BIOTHERAPEUTICS INC | Healthcare | 2,580,556.0 | $5.7M | 0.81% | NEW | — | $2.22 | -14.4% |
| 27 | TMCI | TREACE MEDICAL CONCEPTS INC | Healthcare | 702,245.0 | $4.7M | 0.67% | NEW | — | $6.71 | -59.5% |
| 28 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 100,000.0 | $4.7M | 0.66% | NEW | — | $46.70 | +209.1% |
| 29 | — | KARYOPHARM THERAPEUTICS INC | — | 6,000,000.0 | $4.6M | 0.66% | NEW | — | $0.77 | — |
| 30 | MBX | MBX BIOSCIENCES INC | Healthcare | 253,000.0 | $4.4M | 0.63% | NEW | — | $17.50 | +77.0% |
| 31 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 390,000.0 | $3.6M | 0.51% | NEW | — | $9.15 | +46.8% |
| 32 | ADCT | ADC Therapeutics SA | Healthcare | 682,529.0 | $2.7M | 0.39% | NEW | — | $4.00 | -21.5% |
| 33 | ALMS | ALUMIS INC | Healthcare | 665,000.0 | $2.7M | 0.38% | NEW | — | $3.99 | +439.5% |
| 34 | CABA | CABALETTA BIO INC | Healthcare | 808,882.0 | $1.9M | 0.27% | NEW | — | $2.34 | +39.7% |
| 35 | — | OPUS GENETICS INC | — | 1,100,000.0 | $1.8M | 0.26% | NEW | — | $1.65 | — |
| 36 | — | ZYMEWORKS INC | — | 100,000.0 | $1.7M | 0.24% | NEW | — | $17.08 | — |
| 37 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 65,000.0 | $1.1M | 0.15% | NEW | — | $16.76 | +318.1% |
| 38 | RIGL | RIGEL PHARMACEUTICALS | Healthcare | 37,787.0 | $1.1M | 0.15% | NEW | — | $28.33 | +1.0% |
| 39 | — | ALPHA COGNITION INC | — | 115,142.0 | $750K | 0.11% | NEW | — | $6.51 | — |
| 40 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 316,550.0 | $478K | 0.07% | NEW | — | $1.51 | +140.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%